BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22001709)

  • 1. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
    Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Implantation of Pacemaker/ICDs under Active Oral Anticoagulation Irrespective of Patient's Individual Preoperative Thromboembolic Risk.
    Cano Ó; Andrés A; Jiménez R; Osca J; Alonso P; Rodríguez Y; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A; Martínez-Dolz L
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):723-30. PubMed ID: 25682988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
    Du L; Zhang Y; Wang W; Hou Y
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
    Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
    Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
    Hammerstingl C; Omran H
    Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorrhagic risk of different perioperative anticoagulation protocols in patients implanted with a cardiac pacemaker or defibrillator: retrospective analysis in patients implanted in a community hospital].
    Amara W; Ben Youssef I; Kamel J; Ghrissi I; Faron M; Khouadja A; Sergent J
    Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):265-71. PubMed ID: 19833318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
    Essebag V; Healey JS; Ayala-Paredes F; Kalfon E; Coutu B; Nery P; Verma A; Sapp J; Philippon F; Sandhu RK; Coyle D; Eikelboom J; Wells G; Birnie DH
    Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.
    Sant'anna RT; Leiria TL; Nascimento T; Sant'anna JR; Kalil RA; Lima GG; Verma A; Healey JS; Birnie DH; Essebag V
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):417-23. PubMed ID: 25546244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators.
    Robinson M; Healey JS; Eikelboom J; Schulman S; Morillo CA; Nair GM; Baranchuk A; Ribas S; Evans G; Connolly SJ; Turpie AG
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):378-82. PubMed ID: 19272069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy.
    Spyropoulos AC; Frost FJ; Hurley JS; Roberts M
    Chest; 2004 May; 125(5):1642-50. PubMed ID: 15136371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures.
    Hammerstingl C; Omran H;
    Thromb Haemost; 2009 Jun; 101(6):1085-90. PubMed ID: 19492151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
    Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
    Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline.
    Leijtens B; Kremers van de Hei K; Jansen J; Koëter S
    Arch Orthop Trauma Surg; 2014 Sep; 134(9):1335-41. PubMed ID: 24990654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
    Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.